)
Phio Pharmaceuticals (PHIO) investor relations material
Phio Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for September 28, 2026, at 9:00 a.m. ET, to be held virtually.
Shareholders of record as of August 4, 2026, are eligible to vote on key proposals.
Proxy materials and the 2025 annual report are available online, with options for electronic or paper delivery.
Voting matters and shareholder proposals
Election of six directors: Robert J. Bitterman, Patricia A. Bradford, David H. Deming, Jonathan E. Freeman, Ph.D., Curtis A. Lockshin, Ph.D., and R. Todd Plott, M.D.
Ratification of Grant Thornton, LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Approval of an amendment to the 2020 Long Term Incentive Plan to increase shares available for issuance by 1,500,000.
Board recommends voting FOR all nominees and proposals.
Board of directors and corporate governance
Board slate includes six nominees with diverse backgrounds in business, science, and medicine.
Board oversight includes recommendations on auditor ratification and incentive plan amendments.
- Virtual meeting to elect directors, ratify auditor, and expand equity plan; Board recommends FOR all.PHIO
Proxy filing - PH-762 advanced in Phase 1b as net loss rose and cash runway extended into 2027.PHIO
Q2 2026 - PH-762 achieved high tumor clearance and safety in cSCC, advancing toward further clinical trials.PHIO
Corporate presentation - PH-762 achieved 85% response in phase Ib; INTASYL offers precise, safe, and versatile gene silencing.PHIO
Fireside chat - A new siRNA therapy shows promise for safer, localized skin cancer treatment and future expansion.PHIO
Fireside chat - PH-762 demonstrated high safety and efficacy, positioning INTASYL for major skin cancer markets.PHIO
Life Sciences Virtual Investor Forum - Net loss rose to $4.0M as PH-762 Phase 1b completed; cash runway extends into 2027.PHIO
Q1 2026 - RNA immunotherapy achieved 85% response in skin cancer trial; phase II-B/III planned.PHIO
Second Annual Centri Capital Conference - RNA therapy for skin cancer shows 85% response and no toxicities, advancing to pivotal trials.PHIO
Life Sciences Virtual Investor Forum
Next Phio Pharmaceuticals earnings date
Next Phio Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage